OptimizeRx Corp. (NASDAQ: OPRX), a provider of healthcare technology solutions for life sciences companies, announced that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility consists of a $25 million term loan and a $10 million revolving credit facility that was undrawn at closing. Roth Capital Partners served as financial advisor on the transaction. The full announcement can be viewed at https://ibn.fm/G0Fj3.
This new credit facility provides OptimizeRx with additional financial flexibility to support its strategic initiatives, including potential acquisitions, working capital needs, and general corporate purposes. The company, headquartered in Waltham, Massachusetts, specializes in connecting life science brands with patients and healthcare providers through innovative technology. Its platform combines artificial intelligence-driven tools such as the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between healthcare professional and direct-to-consumer strategies, OptimizeRx aims to drive faster treatment decisions and improve patient outcomes.
The credit facility underscores the confidence that Fifth Third Bank has in OptimizeRx's business model and growth prospects. As a leading healthcare technology company, OptimizeRx partners with some of the world's top pharmaceutical and life sciences companies. The company's commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time.
For more information about OptimizeRx and its solutions, visit www.optimizerx.com. This development is significant as it provides OptimizeRx with the capital necessary to expand its platform and continue transforming the healthcare landscape.
